MCC
GNOM icon

Money Concepts Capital’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Money Concepts Capital’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-486
Closed -$24.6K – 1474
2022
Q4 		$24.6K Buy
+486
New +$25.1K ﹤0.01% 1572

Other funds holding GNOM

Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
PFG
Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

Money Concepts Capital's GNOM Position: Q1 2023 in Review

Money Concepts Capital sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2023, closing a stake of 486 shares — an estimated $24.6K sold.

Money Concepts Capital first reported a position in GNOM in Q4 2022 and held it in 1 quarter. The position peaked at $24.6K in Q4 2022. 63 funds tracked by Wall St. Rank hold GNOM as of Q1 2023.

  • Money Concepts Capital reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 486 Global X Genomics & Biotechnology ETF shares in Q1 2023, an estimated $24.6K.
  • Money Concepts Capital first reported a position in Global X Genomics & Biotechnology ETF in Q4 2022 and held it in 1 quarter.
  • Money Concepts Capital's Global X Genomics & Biotechnology ETF position peaked at $24.6K in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.